Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,709 | 628 | 66.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,800 | 3 | 20.2% |
| Travel and Lodging | $2,725 | 9 | 11.5% |
| Consulting Fee | $525.00 | 1 | 2.2% |
| Education | $13.89 | 1 | 0.1% |
| Entertainment | $4.42 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $10,886 | 153 | $0 (2024) |
| Abbott Laboratories | $2,692 | 51 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,557 | 106 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,397 | 25 | $0 (2020) |
| Medtronic, Inc. | $898.47 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $550.72 | 38 | $0 (2024) |
| Medtronic USA, Inc. | $536.79 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $500.92 | 35 | $0 (2023) |
| Bardy Diagnostics, Inc. | $443.11 | 15 | $0 (2021) |
| BIOTRONIK INC. | $440.13 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,228 | 69 | Abbott Laboratories ($506.67) |
| 2023 | $2,279 | 70 | Boston Scientific Corporation ($858.66) |
| 2022 | $1,737 | 76 | Boston Scientific Corporation ($650.93) |
| 2021 | $1,747 | 56 | BOSTON SCIENTIFIC CORPORATION ($779.76) |
| 2020 | $1,025 | 58 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($302.40) |
| 2019 | $2,955 | 101 | Boston Scientific Corporation ($999.61) |
| 2018 | $2,956 | 119 | BOSTON SCIENTIFIC CORPORATION ($750.00) |
| 2017 | $8,851 | 94 | BOSTON SCIENTIFIC CORPORATION ($6,243) |
All Payment Transactions
643 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $13.88 | General |
| Category: Cardiology | ||||||
| 12/19/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $37.65 | General |
| Category: Transcatheter Valve Systems | ||||||
| 12/19/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $30.04 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $48.79 | General |
| Category: General - EP_EP | ||||||
| 12/18/2024 | Abbott Laboratories | ESPRIT (Device) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Vascular | ||||||
| 12/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.80 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/04/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.54 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/29/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $182.22 | General |
| Category: Electrophysiology | ||||||
| 11/21/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/20/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.60 | General |
| Category: Medical Device | ||||||
| 11/18/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: DEVICES | ||||||
| 10/30/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $50.59 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/24/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.45 | General |
| 10/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.86 | General |
| 10/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.16 | General |
| 10/18/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: DEVICES | ||||||
| 10/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.58 | General |
| 10/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $41.37 | General |
| 10/03/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: EMBLEM_CRM | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $46.36 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $179.65 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,802 | 4,105 | $623,845 | $189,834 |
| 2022 | 32 | 1,697 | 4,037 | $594,220 | $189,577 |
| 2021 | 34 | 1,668 | 3,514 | $505,676 | $169,010 |
| 2020 | 37 | 1,651 | 3,057 | $454,865 | $162,964 |
All Medicare Procedures & Services
138 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 360 | $99,000 | $32,277 | 32.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 75 | 397 | $50,816 | $13,569 | 26.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 75 | 395 | $50,560 | $13,366 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 195 | $39,000 | $12,571 | 32.2% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 31 | 31 | $33,356 | $11,928 | 35.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 97 | 305 | $22,875 | $9,114 | 39.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 24 | 24 | $23,136 | $8,210 | 35.5% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 75 | 432 | $38,940 | $8,104 | 20.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 80 | $20,400 | $7,220 | 35.4% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 11 | 11 | $17,600 | $7,039 | 40.0% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 11 | 11 | $18,700 | $6,100 | 32.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 42 | $17,220 | $5,727 | 33.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 45 | 298 | $26,990 | $5,554 | 20.6% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 16 | 16 | $15,088 | $5,449 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $14,145 | $5,132 | 36.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 85 | 235 | $21,150 | $4,939 | 23.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 24 | 96 | $14,400 | $4,227 | 29.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 24 | 48 | $10,800 | $3,537 | 32.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 79 | 131 | $10,349 | $3,522 | 34.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 55 | 132 | $11,880 | $3,498 | 29.4% |
| 93609 | Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | Facility | 2023 | 15 | 15 | $8,475 | $3,142 | 37.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 99 | 136 | $6,800 | $2,451 | 36.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 126 | 188 | $6,392 | $1,983 | 31.0% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 23 | 40 | $6,000 | $1,826 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,600 | $1,529 | 33.2% |
About Dr. Amit Guttigoli, MD
Dr. Amit Guttigoli, MD is a Cardiovascular Disease healthcare provider based in Duncanville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760417026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Guttigoli, MD has received a total of $23,778 in payments from pharmaceutical and medical device companies, with $2,228 received in 2024. These payments were reported across 643 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($15,709).
As a Medicare-enrolled provider, Guttigoli has provided services to 6,818 Medicare beneficiaries, totaling 14,713 services with total Medicare billing of $711,385. Data is available for 4 years (2020–2023), covering 138 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Duncanville, TX
- Active Since 07/12/2006
- Last Updated 12/12/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1760417026
Products in Payments
- EMBLEM (Device) $4,782
- LifeVest (Device) $1,557
- WATCHMAN (Device) $1,528
- Micra (Device) $1,005
- ELIQUIS (Drug) $772.95
- COREVALVE EVOLUT R (Device) $749.67
- LUX-Dx Insertable Cardiac Monitor (Device) $748.29
- EnSite Velocity System Expansion Modules (Device) $635.97
- LUX DX (Device) $580.09
- XARELTO (Drug) $550.72
- PlasmaBlade (Device) $536.79
- Cardiac Mapping System (Device) $463.54
- Carnation Ambulatory Monitor (Device) $443.11
- ENTRESTO (Drug) $425.13
- GENERAL THERAPIES (Device) $410.14
- GENERAL THERAPIES (Device) $255.53
- Barostim Neo System (Device) $249.62
- FARXIGA (Drug) $240.52
- Peripheral Orbital Atherectomy System (Device) $231.59
- Orsiro Mission (Device) $231.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.